Julietta Fiscella, M.D.
Cytopathology - American Board of Pathology
Pathology, Anatomic Pathology & Clinical Pathology - American Board of Pathology
Clinical Associate Professor (Voluntary) - Department of Pathology and Laboratory Medicine (SMD)
Chief, Pathology, Highland Hosp Labs - Department of Pathology and Laboratory Medicine (SMD)
Residency & Fellowship
Residency, Pathology, University of Rochester Medical Center. 1992 - 1995
Residency, Pathology, University at Buffalo. 1990 - 1992
Internship, Internal Medicine, Sisters of Charity Hospital of Buffalo-GME. 1988 - 1989
MD | SUNY at Buffalo-School of Medicine & Biomedical Sciences (USA). 1988
Introducing Patients to Their Pathology Reports
CAP Today. 2014; 28(1): 54 - 55.
Fiscella, J.; Ahmed, B.
Pathologists Can Explain Surgical Pathology to Patients:
Fiscella J, Bonfiglio T, Winters P, Eisinger SH, Fiscella K
Human pathology.. 2011 July 42 (7):947-53. Epub 02/11/2011.
Distinguishing Features of Endometrial Pathology After Exposure to the Progesterone Receptor Modulator Mifepristone.
Fiscella, J.; Bonfiglio, T.; Winters, P.; Eisenger, S.H.; Fiscella, K.
Human Pathology. 2011; 42(7): 947-953.
Eisinger SH, Fiscella J, Bonfiglio T, Meldrum S, Fiscella K
European journal of obstetrics, gynecology, and reproductive biology.. 2009 October 146 (2):215-8. Epub 07/07/2009.
Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata
Eisinger, S.H.; Fiscella, J.; Bonfiglio, T.; Meldrum, S.; Fiscella, K.
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009; 146: 215-218.
Goedde TA, Bumpers H, Fiscella J, Rao U, Karakousis CP
Journal of surgical oncology.. 1994 April 55 (4):261-4. Epub 1900 01 01.